Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
26.78
-0.34 (-1.25%)
At close: Jan 16, 2026, 4:00 PM EST
26.76
-0.02 (-0.07%)
After-hours: Jan 16, 2026, 7:10 PM EST
Caris Life Sciences Revenue
Caris Life Sciences had revenue of $216.83M in the quarter ending September 30, 2025, with 116.73% growth. This brings the company's revenue in the last twelve months to $649.06M. In the year 2024, Caris Life Sciences had annual revenue of $412.26M with 34.67% growth.
Revenue (ttm)
$649.06M
Revenue Growth
+34.67%
P/S Ratio
4.34
Revenue / Employee
$366,909
Employees
1,769
Market Cap
7.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 412.26M | 106.13M | 34.67% |
| Dec 31, 2023 | 306.13M | 47.64M | 18.43% |
| Dec 31, 2022 | 258.49M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCAI News
- 8 months ago - Caris Life Sciences Files Registration Statement for Proposed Initial Public Offering - PRNewswire
- 8 months ago - Caris Life Sciences discloses rise in revenue in US IPO filing - Reuters
- 8 months ago - Oncology precision medicine platform Caris Life Sciences files for an estimated $300 million IPO - Renaissance Capital
- 8 months ago - Caris Life Sciences IPO Registration Document (S-1) - SEC